TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation
Rhea-AI Summary
TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, has secured a new service provider who invested $185,500 in SteraMist mobile systems and BIT solution. The provider will focus on mold and mycotoxins remediation in healthcare, having already secured a contract to remediate a 400,000-cubic-feet hospital space including HVAC decontamination.
The company also highlighted its ongoing partnership with Enviro-Mist Inc., which maintains a multi-year service contract with Pfizer and continues to use SteraMist technology for mold remediation and decontamination in pharmaceutical facilities across the West Coast.
Positive
- New service provider made significant investment of $185,500 in SteraMist systems
- Provider secured major 400,000-cubic-feet hospital remediation contract
- Ongoing multi-year service contract with Pfizer facility through partner Enviro-Mist
Negative
- Heavy reliance on single or few products for majority of revenues
- Business growth dependent on service provider performance
News Market Reaction
On the day this news was published, TOMZ declined 6.42%, reflecting a notable negative market reaction. Argus tracked a peak move of +7.0% during that session. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $22M at that time.
Data tracked by StockTitan Argus on the day of publication.
FREDERICK, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced a new service provider this quarter, expanding the use of its SteraMist iHP technology. This new provider has invested approximately
"We are incredibly excited to partner with them as they make strides into the healthcare industry," said Elissa J. (E.J.) Shane, COO of TOMI Environmental Solutions. "Their leadership, which includes a prominent figure in restoration and seasoned personnel, brings unique industry and operating expertise. They have been extensively trained on our technology and are well-prepared to deliver exceptional service."
This new service provider also has a working relationship with Enviro-Mist Inc., a long-standing exclusive partner of TOMI and experts in mold remediation. Enviro-Mist Inc. continues to use SteraMist for mold remediation as well as the decontamination of pharmaceutical and life sciences facilities throughout the West Coast, including a multi-year service contract for a Pfizer facility.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve healthcare sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
FAQ
What is the value of the new service provider's investment in TOMI Environmental Solutions (TOMZ)?
What is the size of the hospital contract secured by TOMI's new service provider?
Who are TOMI Environmental Solutions' (TOMZ) key partners for mold remediation?
What is TOMI Environmental Solutions' (TOMZ) main technology?
What industries does TOMI Environmental Solutions (TOMZ) serve?
